Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future evaluation of antiarrhythmic therapy

R J Myerburg1, K M Kessler, S Chakko

  • 1Division of Cardiology, University of Miami School of Medicine, FL 33101.

American Heart Journal
|April 1, 1994
PubMed
Summary

Evaluating antiarrhythmic therapies requires rigorous assessment. New guidelines emphasize placebo-controlled trials to confirm mortality benefits and analyze efficacy, efficiency, and risks for cost-effective treatment decisions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of particle size and interparticle force on the fluidization behavior of gas-fluidized beds.

Physical review. E, Statistical, nonlinear, and soft matter physics·2003
Same author

Pumping of liquids with ac voltages applied to asymmetric pairs of microelectrodes.

Physical review. E, Statistical, nonlinear, and soft matter physics·2003
Same author

Experimental study on the dynamics of gas-fluidized beds.

Physical review. E, Statistical, nonlinear, and soft matter physics·2003
Same author

Fluid flow induced by nonuniform ac electric fields in electrolytes on microelectrodes. III. Observation of streamlines and numerical simulation.

Physical review. E, Statistical, nonlinear, and soft matter physics·2002
Same author

Fine cohesive powders in rotating drums: Transition from rigid-plastic flow to gas-fluidized regime.

Physical review. E, Statistical, nonlinear, and soft matter physics·2002
Same author

Sudden death due to cardiac arrhythmias.

The New England journal of medicine·2002

Area of Science:

  • Cardiology
  • Clinical Trials
  • Pharmacology

Background:

  • Antiarrhythmic therapy now includes surgery, devices, and ablation, expanding beyond drugs.
  • The Cardiac Arrhythmia Suppression Trial (CAST) highlighted the need for placebo-controlled trials to prove mortality benefits.

Purpose of the Study:

  • To define the requirements for evaluating antiarrhythmic therapies.
  • To outline a framework for assessing therapy efficacy, efficiency, and risk-benefit profiles.

Main Methods:

  • Categorization of pharmacologic therapy into primary, alternative, and adjunctive approaches.
  • Identification of four key variables for therapy evaluation: efficacy/efficiency, competing risks, life extension, and benefit-risk equilibrium.

Main Results:

Related Experiment Videos

  • Primary therapy requires placebo-controlled studies for mortality benefit confirmation.
  • Symptom control can be assessed with less rigorous methods.
  • Current data are limited by a lack of true negative controls for interventions claiming mortality benefits.

Conclusions:

  • A rational analysis of antiarrhythmic therapy requires evaluating efficacy, efficiency, competing risks, life extension, and the balance between antiarrhythmic and proarrhythmic effects.
  • This comprehensive evaluation enables a cost-benefit analysis of treatments.